Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Susie H. Park, PharmD

    TitleAssociate Dean For Student Affairs
    SchoolSchool of Pharmacy
    DepartmentClinical Pharmacy and Pharmaceutical Econ. and Policy
    AddressPSC 700C
    Health Sciences Campus
    Los Angeles California 90089-9121
    Phone+1 323 442 1675
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Park received her Pharm.D. from the University of Southern California, School of Pharmacy. She completed a one-year residency in psychiatric pharmacy practice and subsequently obtained the Board of Pharmaceutical Specialty in psychiatry. Currently, she is an Assistant Professor of Clinical Pharmacy and Pharmaceutical Economics and Policy.

      Collapse Biography 
      Collapse Awards and Honors
      USC Keck School of Medicine2013Recognition Award for Excellence in Teaching
      USC School of Pharmacy2013Professor of the Year Level Four
      USC School of Pharmacy 2011Psychiatric Care Outstanding Preceptor
      California Society of Health-System Pharmacists 2010Practitioner Fellow
      USC School of Pharmacy2007Phi Lambda Sigma Leadership Mentoring Award
      Wal-Mart Annual Conference Scholarship for Mentor-Student2006American Association of Colleges of Pharmacy
      Rho Chi (Theta Chapter)2006Honorary Member
      USC School of Pharmacy2001  - 2007Professor of the Year Level Four

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Jiang Y, McCombs JS, Park S. A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics. CNS Drugs. 2017 Apr; 31(4):319-326. PMID: 28290080.
        View in: PubMed
      2. Williams AM, Park S. Seizure associated with clozapine: incidence, etiology, and management. CNS Drugs. 2015 Feb; 29(2):101-11. PMID: 25537107.
        View in: PubMed
      3. Park S, Wackernah RC, Stimmel GL. Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants? J Pharm Pract. 2014 Feb; 27(1):71-8. PMID: 24153222.
        View in: PubMed
      4. Park S, Ishino R. Liver injury associated with antidepressants. Curr Drug Saf. 2013 Jul; 8(3):207-23. PMID: 23914755.
        View in: PubMed
      5. Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2013 Sep; 120(9):1860-70. PMID: 23642377; PMCID: PMC3737287.
      6. Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology. 2013 Mar; 120(3):593-9. PMID: 23337555; PMCID: PMC3633658.
      7. Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology. 2013 Jan; 120(1):122-9. PMID: 23047002; PMCID: PMC3536921.
      8. Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012 Jul; 119(7):1388-98. PMID: 22555112; PMCID: PMC3389193.
      9. Park S. Completion of chronic hepatitis C virus treatment in interferon-induced major depressive disorder with psychotic features. Psychiatry Investig. 2011 Dec; 8(4):381-3. PMID: 22216051; PMCID: PMC3246149.
      10. Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med. 2012 Jan 05; 366(1):20-33. PMID: 22077816.
        View in: PubMed
      11. Shen KK, Fripp J, Mériaudeau F, Chételat G, Salvado O, Bourgeat P. Detecting global and local hippocampal shape changes in Alzheimer's disease using statistical shape models. Neuroimage. 2012 Feb 01; 59(3):2155-66. PMID: 22037419.
        View in: PubMed
      12. Cho Y, Seong JK, Jeong Y, Shin SY. Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data. Neuroimage. 2012 Feb 01; 59(3):2217-30. PMID: 22008371.
        View in: PubMed
      13. Wackernah RC, Lou M, Park S. Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virus. Clin Ther. 2011 Oct; 33(10):1400-5. PMID: 21982383.
        View in: PubMed
      14. Eskildsen SF, Coupé P, Fonov V, Manjón JV, Leung KK, Guizard N, Wassef SN, Østergaard LR, Collins DL. BEaST: brain extraction based on nonlocal segmentation technique. Neuroimage. 2012 Feb 01; 59(3):2362-73. PMID: 21945694.
        View in: PubMed
      15. Tasoglu S, Peters JJ, Park S, Verguet S, Katz DF, Szeri AJ. The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle. Phys Fluids (1994). 2011 Sep; 23(9):93101-931019. PMID: 21998495.
        View in: PubMed
      16. Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L. Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med. 2011 Aug 25; 365(8):699-708. PMID: 21780946.
        View in: PubMed
      17. Haller JA, Bandello F, Belfort R, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM, Li J. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011 Dec; 118(12):2453-60. PMID: 21764136.
        View in: PubMed
      18. Tasoglu S, Park S, Peters JJ, Katz DF, Szeri AJ. The consequences of yield stress on deployment of a non-Newtonian anti-HIV microbicide gel. J Nonnewton Fluid Mech. 2011 Oct; 166(19-20):1116-1122. PMID: 22563138.
        View in: PubMed
      19. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011 May 19; 364(20):1897-908. PMID: 21526923; PMCID: PMC3157322.
      20. McEvoy LK, Holland D, Hagler DJ, Fennema-Notestine C, Brewer JB, Dale AM. Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis. Radiology. 2011 Jun; 259(3):834-43. PMID: 21471273; PMCID: PMC3099042.
      21. Schott JM. Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiol Aging. 2012 Jul; 33(7):1486.e9-15. PMID: 21459483; PMCID: PMC3150628.
      22. Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain. 2011 Apr; 134(Pt 4):1077-88. PMID: 21429865; PMCID: PMC3069703.
      23. Kauwe JS, Cruchaga C, Karch CM, Sadler B, Lee M, Mayo K, Latu W, Su'a M, Fagan AM, Holtzman DM, Morris JC, Goate AM. Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease. PLoS One. 2011 Feb 09; 6(2):e15918. PMID: 21347408; PMCID: PMC3036586.
      24. Katz AR, Buchholz AE, Hinson K, Park S, Effler PV. Leptospirosis in Hawaii, USA, 1999-2008. Emerg Infect Dis. 2011 Feb; 17(2):221-6. PMID: 21291592; PMCID: PMC3204774.
      25. Gu J, MacHugh DE, McGivney BA, Park S, Katz LM, Hill EW. Association of sequence variants in CKM (creatine kinase, muscle) and COX4I2 (cytochrome c oxidase, subunit 4, isoform 2) genes with racing performance in Thoroughbred horses. Equine Vet J Suppl. 2010 Nov; (38):569-75. PMID: 21059062.
        View in: PubMed
      26. Haller JA, Bandello F, Belfort R, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010 Jun; 117(6):1134-1146.e3. PMID: 20417567.
        View in: PubMed
      27. McGivney BA, Eivers SS, MacHugh DE, MacLeod JN, O'Gorman GM, Park S, Katz LM, Hill EW. Transcriptional adaptations following exercise in thoroughbred horse skeletal muscle highlights molecular mechanisms that lead to muscle hypertrophy. BMC Genomics. 2009 Dec 30; 10:638. PMID: 20042072; PMCID: PMC2812474.
      28. Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J. Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J. 2009 Dec; 158(6):896-901.e3. PMID: 19958854.
        View in: PubMed
      29. Eivers SS, McGivney BA, Fonseca RG, MacHugh DE, Menson K, Park S, Rivero JL, Taylor CT, Katz LM, Hill EW. Alterations in oxidative gene expression in equine skeletal muscle following exercise and training. Physiol Genomics. 2010 Jan 08; 40(2):83-93. PMID: 19861432.
        View in: PubMed
      30. Gu J, Orr N, Park S, Katz LM, Sulimova G, MacHugh DE, Hill EW. A genome scan for positive selection in thoroughbred horses. PLoS One. 2009 Jun 02; 4(6):e5767. PMID: 19503617; PMCID: PMC2685479.
      31. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009 Jun 18; 360(25):2605-15. PMID: 19423869.
        View in: PubMed
      32. Szeri AJ, Park S, Verguet S, Weiss A, Katz DF. A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding. Phys Fluids (1994). 2008 Aug; 20(8):83101. PMID: 19547722.
        View in: PubMed
      33. Gaynor K, Katz AR, Park S, Nakata M, Clark TA, Effler PV. Leptospirosis on Oahu: an outbreak associated with flooding of a university campus. Am J Trop Med Hyg. 2007 May; 76(5):882-5. PMID: 17488909.
        View in: PubMed
      34. Kim JW, Park S, Louie SG. Telbivudine: a novel nucleoside analog for chronic hepatitis B. Ann Pharmacother. 2006 Mar; 40(3):472-8. PMID: 16507625.
        View in: PubMed
      35. Kim J, Phongsamran P, Park S. Use of antidepressant drugs in transplant recipients. Prog Transplant. 2004 Jun; 14(2):98-104. PMID: 15264454.
        View in: PubMed
      36. Schneider LS, Katz IR, Park S, Napolitano J, Martinez RA, Azen SP. Psychosis of Alzheimer disease: validity of the construct and response to risperidone. Am J Geriatr Psychiatry. 2003 Jul-Aug; 11(4):414-25. PMID: 12837670.
        View in: PubMed
      37. Park S, Gill MA, Dopheide JA. Visual compatibility of risperidone solution and lithium citrate syrup. Am J Health Syst Pharm. 2003 Mar 15; 60(6):612-3. PMID: 12659069.
        View in: PubMed